Sunday, March 2, 2014

CVS Caremark: Everyone Should Love A Quitter

CVS Caremark (CVS) made big news in February when the company announced that it would stop selling all tobacco products at its 7,600 pharmacy locations by October. This move, although expected to pressure CVS Caremark's revenue and earnings per share growth in the short-term, is a smart move that should help preserve the company's long-term growth trajectory.

Click here to learn how CVS Caremark is changing the American pharmacy landscape for the better and how investors stand to benefit. Enjoy!


No comments:

Post a Comment